This paper is in the following e-collection/theme issue:

mHealth for Wellness, Behavior Change and Prevention (2922) Coronary Heart Disease (81)

Published on in Vol 6, No 1 (2018): January

Using Mobile Health Intervention to Improve Secondary Prevention of Coronary Heart Diseases in China: Mixed-Methods Feasibility Study

Using Mobile Health Intervention to Improve Secondary Prevention of Coronary Heart Diseases in China: Mixed-Methods Feasibility Study

Using Mobile Health Intervention to Improve Secondary Prevention of Coronary Heart Diseases in China: Mixed-Methods Feasibility Study

Authors of this article:

Shu Chen1 Author Orcid Image ;   Enying Gong1 Author Orcid Image ;   Dhruv S Kazi2, 3, 4 Author Orcid Image ;   Ann B Gates5 Author Orcid Image ;   Rong Bai6, 7 Author Orcid Image ;   Hua Fu8 Author Orcid Image ;   Weixia Peng8 Author Orcid Image ;   Ginny De La Cruz9 Author Orcid Image ;   Lei Chen10 Author Orcid Image ;   Xianxia Liu10 Author Orcid Image ;   Qingjie Su11 Author Orcid Image ;   Nicolas Girerd12, 13 Author Orcid Image ;   Kamilu M Karaye14 Author Orcid Image ;   Khalid F Alhabib15 Author Orcid Image ;   Lijing L. Yan1, 16 Author Orcid Image ;   JD Schwalm17, 18 Author Orcid Image
Article Authors Cited by (24) Tweetations (29) Metrics

Shu Chen   1 , MSc ;   Enying Gong   1 , MSc ;   Dhruv S Kazi   2, 3, 4 , MSc, MD ;   Ann B Gates   5 , BPharm (Hons) ;   Rong Bai   6, 7 , MD ;   Hua Fu   8 , PhD ;   Weixia Peng   8 , PhD ;   Ginny De La Cruz   9 , MSc ;   Lei Chen   10 , MD ;   Xianxia Liu   10 , MD ;   Qingjie Su   11 , MD ;   Nicolas Girerd   12, 13 , MPH, MD, PhD ;   Kamilu M Karaye   14 , FWACP, MBBS, PhD ;   Khalid F Alhabib   15 , MBBS, FESC, FACC, FRCPC ;   Lijing L. Yan   1, 16 , MPH, PhD ;   JD Schwalm   17, 18 , MD

1 Global Health Research Center, Duke Kunshan University, Kunshan, China

2 Department of Medicine (Cardiology), University of California, San Francisco, San Francisco, CA, United States

3 Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, United States

4 Division of Cardiology, Zuckerberg San Francisco General Hospital, San Francisco, CA, United States

5 Exercise Works Ltd., Derby, United Kingdom

6 National Clinical Research Center for Cardiovascular Diseases, Beijing, China

7 Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China

8 School of Public Health, Fudan University, Shanghai, China

9 Global Health Research Center, Duke Kunshan University, Kunshan, China

10 Department of Cardiology, Hainan Provincial Nongken General Hospital, Haikou, China

11 Department of Neurology, Hainan Provincial Nongken General Hospital, Haikou, China

12 Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu, Centre d’Investigations Cliniques, Centre Hospitalier Universitaire de Nancy, Nancy, France

13 Cardiovascular and Renal Clinical Trialists, French Clinical Research Infrastructure Network, Nancy, France

14 Department of Medicine, Bayero University/Aminu Kano Teaching Hospital, Kano, Nigeria

15 Department of Cardiac Sciences, King Fahad Cardiac Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia

16 Duke Global Health Institute, Duke University, Durham, NC, United States

17 Population Health Research Institute, Hamilton Health Sciences, Hamilton, ON, Canada

18 Division of Orthopaedic Surgery, University of Toronto, Toronto, ON, Canada

Corresponding Author:

  • Lijing L. Yan, MPH, PhD
  • Global Health Research Center
  • Duke Kunshan University
  • No 8 Duke Avenue, Duke Kunshan University, Kunshan, Jiangsu, China
  • Kunshan, 215316
  • China
  • Phone: 86 51236657057
  • Fax: 86 51257728899
  • Email: lijing.yan@duke.edu